Nova Mentis Life Stock Profit Margin
| NMLSF Stock | USD 0.03 0 6.14% |
Nova Mentis Life fundamentals help investors to digest information that contributes to Nova Mentis' financial success or failures. It also enables traders to predict the movement of Nova Pink Sheet. The fundamental analysis module provides a way to measure Nova Mentis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Mentis pink sheet.
Nova |
Nova Mentis Life Company Profit Margin Analysis
Nova Mentis' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Nova Mentis Life has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Nova Fundamentals
| Return On Equity | -0.89 | |||
| Return On Asset | -0.52 | |||
| Current Valuation | 5.46 M | |||
| Shares Outstanding | 143.47 M | |||
| Shares Owned By Insiders | 11.73 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Book | 7.68 X | |||
| Price To Sales | 5,731 X | |||
| Gross Profit | (5.44 K) | |||
| EBITDA | (2.93 M) | |||
| Net Income | (2.68 M) | |||
| Cash And Equivalents | 634.36 K | |||
| Current Ratio | 4.50 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.95 M) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | 0.86 | |||
| Market Capitalization | 7.7 M | |||
| Total Asset | 881.16 K | |||
| Z Score | -9.9 | |||
| Net Asset | 881.16 K |
About Nova Mentis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Mentis Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Mentis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Mentis Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Nova Pink Sheet
Nova Mentis financial ratios help investors to determine whether Nova Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Mentis security.